{"id":"https://openalex.org/W2802276893","doi":"https://doi.org/10.1212/wnl.90.15_supplement.ct.002","title":"Effects of IONIS-HTTRx in Patients with Early Huntington\u2019s Disease, Results of the First HTT-Lowering Drug Trial (CT.002)","display_name":"Effects of IONIS-HTTRx in Patients with Early Huntington\u2019s Disease, Results of the First HTT-Lowering Drug Trial (CT.002)","publication_year":2018,"publication_date":"2018-04-10","ids":{"openalex":"https://openalex.org/W2802276893","doi":"https://doi.org/10.1212/wnl.90.15_supplement.ct.002","mag":"2802276893"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.90.15_supplement.ct.002","doi":"https://doi.org/10.1212/wnl.90.15_supplement.ct.002","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.90.15_supplement.ct.002","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041885603","display_name":"Sarah J. Tabrizi","orcid":"https://orcid.org/0000-0003-2716-2045","observed_orcids":["https://orcid.org/0000-0003-2716-2045","https://orcid.org/0000-0001-8055-2208"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Tabrizi","raw_affiliation_strings":["University College London London United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London London United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062884561","display_name":"Blair R. Leavitt","orcid":"https://orcid.org/0000-0002-4532-766X","observed_orcids":["https://orcid.org/0000-0002-4532-766X"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Blair Leavitt","raw_affiliation_strings":["University of British Columbia Vancouver BC Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of British Columbia Vancouver BC Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046921947","display_name":"Holly B. Kordasiewicz","orcid":"https://orcid.org/0009-0004-0945-0769","observed_orcids":["https://orcid.org/0009-0004-0945-0769"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Holly Kordasiewicz","raw_affiliation_strings":["Ionis Pharmaceuticals Carlsbad CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals Carlsbad CA United States","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065043368","display_name":"Christian Czech","orcid":"https://orcid.org/0000-0001-7746-0134","observed_orcids":["https://orcid.org/0000-0001-7746-0134"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Christian Czech","raw_affiliation_strings":["F. Hoffman-La Roche Ltd. Basel Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffman-La Roche Ltd. Basel Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009098620","display_name":"Eric E. Swayze","orcid":"https://orcid.org/0000-0001-6430-6576","observed_orcids":["https://orcid.org/0000-0001-6430-6576"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Swayze","raw_affiliation_strings":["Ionis Pharmaceuticals Carlsbad CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals Carlsbad CA United States","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041113915","display_name":"Daniel A. Norris","orcid":"https://orcid.org/0000-0003-2074-5862","observed_orcids":["https://orcid.org/0000-0003-2074-5862"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A. Norris","raw_affiliation_strings":["Ionis Pharmaceuticals Carlsbad CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals Carlsbad CA United States","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056603030","display_name":"Tiffany L. Baumann","orcid":"https://orcid.org/0000-0002-1672-4025","observed_orcids":["https://orcid.org/0000-0002-1672-4025"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tiffany Baumann","raw_affiliation_strings":["Ionis Pharmaceuticals Carlsbad CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals Carlsbad CA United States","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Irene Gerlach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Irene Gerlach","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd Basel Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd Basel Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008618034","display_name":"Scott Schobel","orcid":"https://orcid.org/0000-0001-6182-1943","observed_orcids":["https://orcid.org/0000-0001-6182-1943"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Scott Schobel","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd. Basel Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd. Basel Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054594438","display_name":"Anne V. Smith","orcid":"https://orcid.org/0000-0001-8190-3006","observed_orcids":["https://orcid.org/0000-0001-8190-3006"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Smith","raw_affiliation_strings":["Ionis Pharmaceuticals Carlsbad CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals Carlsbad CA United States","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112435094","display_name":"Roger M. Lane","orcid":"https://orcid.org/0009-0004-9301-6083","observed_orcids":["https://orcid.org/0009-0004-9301-6083"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger Lane","raw_affiliation_strings":["Ionis Pharmaceuticals Carlsbad CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals Carlsbad CA United States","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083296071","display_name":"C. Frank Bennett","orcid":"https://orcid.org/0000-0001-9887-6251","observed_orcids":["https://orcid.org/0000-0001-9887-6251"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Frank Bennett","raw_affiliation_strings":["Ionis Pharmaceuticals Carlsbad CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ionis Pharmaceuticals Carlsbad CA United States","institution_ids":["https://openalex.org/I2800035258"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1627,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.87315281,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"90","issue":"15_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.878000020980835},{"id":"https://openalex.org/keywords/huntington-s-disease","display_name":"Huntington's disease","score":0.8669999837875366},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8190000057220459},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":1.0},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6862818002700806},{"id":"https://openalex.org/C2780647506","wikidata":"https://www.wikidata.org/wiki/Q190564","display_name":"Huntington's disease","level":3,"score":0.6691011190414429},{"id":"https://openalex.org/C2992672634","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Drug trial","level":3,"score":0.6435264348983765},{"id":"https://openalex.org/C2777842544","wikidata":"https://www.wikidata.org/wiki/Q9056","display_name":"Czech","level":2,"score":0.6140430569648743},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.41403859853744507},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.38980984687805176},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3608558773994446},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29263579845428467},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2837757468223572},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.11680755019187927},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.04297003149986267}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.90.15_supplement.ct.002","doi":"https://doi.org/10.1212/wnl.90.15_supplement.ct.002","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.90.15_supplement.ct.002","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2891263300","https://openalex.org/W2526348597","https://openalex.org/W4232877437","https://openalex.org/W2950101483","https://openalex.org/W2795150695","https://openalex.org/W4415625862","https://openalex.org/W3012750149","https://openalex.org/W2057758054","https://openalex.org/W2561171283","https://openalex.org/W2944399192"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"characterize":[2],"safety,":[3,173],"tolerability,":[4],"pharmacokinetics":[5],"(PK)":[6],"and":[7,85,175,196,220,222],"pharmacodynamics":[8],"(PD)":[9],"of":[10,77,143,172,311,361,364],"IONIS-HTT":[11,144,183,270,302],"Rx":[12,145,184,271,303],",":[13],"an":[14,37,356],"antisense":[15],"oligonucleotide":[16],"(ASO)":[17],"designed":[18],"to":[19,108,116,139,179,198,251,255,323,507],"target":[20,176],"huntingtin":[21,58],"(":[22],"HTT":[23,49,80,118,123,241],")":[24],"mRNA,":[25],"in":[26,47,52,55,206,218,238,265,295,355],"patients":[27,135,210,256],"with":[28,61,113,165,227,257,279,343,395,416,437,458,479,500],"early":[29,266],"manifest":[30],"Huntington\u2019s":[31,365],"disease":[32,41,65,83,87],"(HD).":[33],"Background:":[34],"HD":[35,268],"is":[36,304],"autosomal":[38],"dominant":[39],"neurodegenerative":[40,258],"caused":[42],"by":[43,148,155],"CAG":[44],"repeat":[45],"expansion":[46,54],"the":[48,56,249,287,309,362],"gene":[50],"resulting":[51],"polyglutamine":[53],"mutant":[57,240],"protein":[59],"(mHTT)":[60,242],"a":[62,110,156,230,305,335,387,408,429,450,471,492],"toxic":[63],"gain-of-function":[64],"mechanism.":[66],"No":[67,209],"disease-modifying":[68,253],"treatments":[69],"are":[70],"currently":[71],"available.":[72],"In":[73,126,260],"transgenic":[74],"rodent":[75],"models":[76],"HD,":[78],"suppressing":[79],"production":[81],"delays":[82],"progression":[84],"reverses":[86],"phenotype":[88],"(Kordasiewicz":[89],"et":[90,94],"al.":[91,95],"2012;":[92],"Stanek":[93],"2013).":[96],"A":[97],"comprehensive":[98],"drug":[99],"discovery":[100],"effort,":[101],"including":[102],"extensive":[103],"preclinical":[104,233],"testing,":[105],"was":[106,185,216,276],"undertaken":[107],"design":[109],"well-tolerated":[111,186],"ASO":[112,215,246],"high":[114],"specificity":[115],"human":[117],"mRNA":[119],"that":[120,301],"potently":[121],"suppresses":[122],"production.":[124],"Design/Methods:":[125],"this":[127,261],"first-in-human,":[128],"multi-center,":[129],"double-blind":[130],"clinical":[131],"trial":[132,264],"(NCT02519036),":[133],"46":[134],"were":[136,163,193,202,224,243,298],"randomized":[137],"(3:1)":[138],"receive":[140],"four":[141],"doses":[142,189],"or":[146,289,340,392,413,434,455,476,497],"placebo":[147],"monthly":[149],"bolus":[150],"intrathecal":[151],"(IT)":[152],"injection":[153,275],"followed":[154],"4-month":[157],"untreated":[158],"period.":[159],"Five":[160],"ascending-dose":[161],"cohorts":[162],"enrolled":[164],"independent":[166],"Data":[167],"Safety":[168],"Monitoring":[169],"Board":[170],"review":[171],"PK":[174],"engagement":[177],"prior":[178],"dose":[180],"escalation.":[181],"Results:":[182],"at":[187],"all":[188],"tested.":[190],"Adverse":[191],"events":[192],"mostly":[194],"mild":[195],"unrelated":[197],"study":[199,281],"drug.":[200],"There":[201],"no":[203,280],"adverse":[204,283],"trends":[205],"laboratory":[207],"parameters.":[208],"prematurely":[211],"discontinued":[212],"from":[213,229,373],"treatment.":[214],"measurable":[217],"CSF":[219,239,296],"plasma,":[221],"concentrations":[223],"generally":[225],"aligned":[226],"predictions":[228],"linked":[231],"PK/PD":[232],"model.":[234],"Significant,":[235],"dose-dependent":[236,293],"reductions":[237,294],"observed.":[244],"Conclusions:":[245],"technology":[247],"has":[248,321,327,351,369,379,400,421,442,463,484,505],"potential":[250],"provide":[252],"benefits":[254],"diseases.":[259],"Phase":[262],"1/2a":[263],"stage":[267],"patients,":[269],"delivered":[272],"via":[273],"IT":[274],"well":[277],"tolerated":[278],"drug-related":[282],"safety":[284],"signals":[285],"during":[286],"treatment":[288,310],"follow-up":[290],"periods.":[291],"Significant":[292],"mHTT":[297],"observed,":[299],"suggesting":[300],"promising":[306],"therapeutic":[307],"for":[308,331,359,383,404,425,446,467,488],"HD.":[312],"Study":[313],"Supported":[314],"by:":[315],"Ionis":[316,396,417,438,459,480,501],"Pharmaceuticals":[317],"Disclosure:":[318],"Dr.":[319,325,349,367,377,398,419,440,461,482,503],"Tabrizi":[320],"nothing":[322,506],"disclose.":[324,508],"Leavitt":[326,350,368],"received":[328,352,370,380,401,422,443,464,485],"personal":[329,353,381,402,423,444,465,486],"compensation":[330,354,382,403,424,445,466,487],"consulting,":[332,384,405,426,447,468,489],"serving":[333,385,406,427,448,469,490],"on":[334,386,407,428,449,470,491],"scientific":[336,388,409,430,451,472,493],"advisory":[337,389,410,431,452,473,494],"board,":[338,390,411,432,453,474,495],"speaking,":[339,391,412,433,454,475,496],"other":[341,393,414,435,456,477,498],"activities":[342,394,415,436,457,478,499],"Roche,":[344],"Ionis,":[345],"uniQure,":[346,375],"Teva,":[347,374],"Lifemax.":[348,376],"editorial":[357],"capacity":[358],"Editor-in-chief":[360],"Journal":[363],"Disease.":[366],"research":[371],"support":[372],"Kordasiewcz":[378],"Pharmaceuticals.":[397,418,439,460,481,502],"Swayze":[399],"Norris":[420],"Baumann":[441],"Smith":[462],"Lane":[483],"Bennett":[504]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":4}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2018-05-17T00:00:00"}